Back to search
P-522 A phase II trial of Alimta plus carboplatin (AC) in patients (pts) with advanced non-small-cell lung cancer (NSCLC)
Data up to Jan 2025
Published2003
Citations7
References0
Total Citations Per Year
Abstract
References (0)
No references found
Cited By (0)
Loading...